MSL
IRWD icon

Mackay Shields LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mackay Shields LLC’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-112,519
Closed -$1.26M – 1011
2021
Q1 		$1.26M Sell
112,519
-71,772
-39% -$758K 0.01% 935
2020
Q4 		$2.1M Buy
184,291
+17,000
+10% +$186K 0.01% 834
2020
Q3 		$1.5M Buy
167,291
+42,900
+34% +$426K 0.01% 893
2020
Q2 		$1.28M Buy
124,391
+10,100
+9% +$103K 0.01% 944
2020
Q1 		$1.15M Sell
114,291
-10,600
-8% -$125K 0.01% 900
2019
Q4 		$1.66M Sell
124,891
-8,200
-6% -$90.4K 0.01% 941
2019
Q3 		$1.14M Sell
133,091
-300
-0.2% -$2.92K 0.01% 1078
2019
Q2 		$1.46M Buy
133,391
+71,997
+117% +$807K 0.01% 1022
2019
Q1 		$695K Buy
61,394
+597
+1% +$6.67K 0.01% 1099
2018
Q4 		$528K Sell
60,797
-6,388
-10% -$73.3K ﹤0.01% 1129
2018
Q3 		$1.04M Buy
67,185
+9,313
+16% +$147K 0.01% 867
2018
Q2 		$927K Sell
57,872
-9,313
-14% -$138K 0.01% 973
2018
Q1 		$868K Buy
+67,185
New +$837K 0.01% 1008

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Mackay Shields LLC's IRWD Position: Q2 2021 in Review

Mackay Shields LLC sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 112,519 shares — an estimated $1.26M sold.

Mackay Shields LLC first reported a position in IRWD in Q1 2018 and held it in 13 quarters. The position peaked at $2.1M in Q4 2020. 208 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • Mackay Shields LLC reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 112,519 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $1.26M.
  • Mackay Shields LLC first reported a position in Ironwood Pharmaceuticals in Q1 2018 and held it in 13 quarters.
  • Mackay Shields LLC's Ironwood Pharmaceuticals position peaked at $2.1M in Q4 2020.
  • 208 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.